BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Start by asking your clinician about FDA‑approved hormone therapy — specifically transdermal estradiol (patch/gel) plus micronized progesterone if you have a uterus — because these have the clearest safety data and consistent dosing.
• Compounded “BHRT” (customized creams, troches, or pellets) is sometimes useful for special needs but is not uniformly regulated and has less evidence. Use it only under close supervision and from a PCAB/USP‑accredited compounding pharmacy if necessary.

What the terms mean (brief)

• Traditional HRT: FDA‑approved products that may be bioidentical (estradiol, micronized progesterone) or non‑bioidentical (conjugated equine estrogens, synthetic progestins).
• BHRT (bioidentical hormone replacement therapy): usually means hormones chemically identical to human hormones (estradiol, progesterone, testosterone). BHRT can be FDA‑approved (e.g., estradiol products, Prometrium) or compounded (custom formulations made by compounding pharmacies). The problems are that compounded products aren’t FDA‑tested for quality, consistency, or labeling.

Why most specialists start with FDA‑approved products

• Consistent dosing and manufacturing quality.
• Better safety and efficacy data from clinical trials.
• Ability to choose routes that lower certain risks (e.g., transdermal estradiol has lower venous thromboembolism risk than oral estrogen).
• Easier follow‑up and known interactions.

Specific products and why you might ask for them

• Transdermal estradiol patches/gels (brands: Climara, Vivelle‑Dot, Estraderm; gels: EstroGel) — preferred if you have VTE risk factors or want lower clot risk.
• Oral estradiol (Estrace) — an alternative if you prefer pills.
• Vaginal/local estrogen (Vagifem tablets, Estring ring, Estrace cream) — for isolated genitourinary symptoms with minimal systemic exposure.
• Micronized progesterone (Prometrium) — a bioidentical, FDA‑approved progesterone often preferred over synthetic progestins (Medroxyprogesterone acetate/Provera) because it may have a different side‑effect profile.
• Conjugated equine estrogens (Premarin) and synthetic progestins (Provera) — effective options historically used; discuss risks/benefits with your clinician.
• Testosterone for women — generally off‑label; some FDA‑approved male products exist but female dosing is specialized. Approach cautiously with a menopause specialist or endocrinologist.

Compounded BHRT and pellets

• Companies/approaches to be cautious about: pellet implants (brands/clinics like BioTE or SottoPelle) and many custom creams/troches. Evidence for long‑term safety and consistency is limited, and pellets can cause issues (infection, unpredictable hormone levels).
• If you need compounded hormones (allergy to an excipient, unique dosing): insist on a PCAB‑accredited or USP‑compliant compounding pharmacy and a prescriber experienced with compounded therapy.

Where to go / who to ask

• Start with your OB‑GYN or primary care clinician and say you want an evidence‑based discussion about hormone therapy for menopausal symptoms.
• For complex cases, uncontrolled symptoms, or if you want an expert opinion: seek a menopause specialist or an endocrinologist. Look for clinicians certified or affiliated with the North American Menopause Society (NAMS).
• Reputable centers: major academic centers/menopause clinics (e.g., Mayo Clinic, Cleveland Clinic, university medical centers) have established menopause programs.
• If considering compounded products, use a PCAB‑accredited compounding pharmacy (check PCAB.org) and a prescriber who monitors levels and symptoms.

What to ask your clinician (sample script)

• “Given my symptoms and medical history, what are the pros/cons of transdermal estradiol vs oral estrogen for me?”
• “If I have a uterus, do I need progesterone? Which progesterone do you recommend (micronized Prometrium vs synthetic)?”
• “Can we use FDA‑approved bioidentical products first? If not effective, under what circumstances would you consider compounded BHRT or pellets?”
• “What baseline labs or screenings do you recommend (mammogram, lipid panel, BP)? How will you monitor therapy and side effects?”
• “I’ve read about saliva hormone tests — do you recommend them?” (Short answer: they are not reliable for guiding therapy.)

Safety, contraindications, and monitoring (key points)

• Contraindications commonly include current or recent breast cancer, active thromboembolic disease, uncontrolled cardiovascular disease — discuss your personal risks.
• Transdermal estradiol is often chosen if clot risk is a concern.
• Use the lowest effective dose for your symptoms and re‑assess regularly (at least annually).
• Routine hormone blood testing for dose adjustment is generally unnecessary; focus on symptom control and safety monitoring.

Bottom line recommendation

• Ask first for discussion of evidence‑based, FDA‑approved options — especially transdermal estradiol plus micronized progesterone (Prometrium) if indicated. Seek care from an OB‑GYN, menopause specialist, or endocrinologist. Consider compounded BHRT only for specific needs, from accredited compounding pharmacies and with close medical supervision. Avoid unvalidated tests (saliva) and be cautious about pellet programs unless benefits clearly outweigh risks for you.

If you want, tell me:

• your age, symptoms, medical history (esp. history of blood clots, breast cancer, stroke, heart disease), and whether you have a uterus — and I can suggest a more tailored set of questions and likely options to discuss with a clinician.